Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease

Pankaj Hari(Indian Council of Medical Research), Arvind Bagga(All India Institute of Medical Sciences), Smriti Hari(All India Institute of Medical Sciences), Ashima Gulati(All India Institute of Medical Sciences), Nandita Gupta(All India Institute of Medical Sciences), Puneet Mahajan(Research Triangle Park Foundation)
Pediatric Nephrology
September 24, 2010
10.1007/s00467-010-1639-2
Cited by 46

Related Papers

Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
The Costs of Treating COPD in the United States
|CHEST Journal|2001|288
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216